PlainRecalls
FDA Devices Moderate Class II Ongoing

CD11b APC: ASR, REF: 340936, and CE, REF: 333143

Reported: January 17, 2024 Initiated: October 25, 2023 #Z-0641-2024

Product Description

CD11b APC: ASR, REF: 340936, and CE, REF: 333143

Reason for Recall

In vitro diagnostics product that impacts the quality of cell staining can cause low or dim fluorescence signal, which can lead to potential false negative results and misdiagnosis of hematological malignancy, delayed treatment, and the need for additional patient samples.

Details

Units Affected
464 Vials
Distribution
Worldwide - US Nationwide distribution including in the states of IL, MN, FL, MI, MD, NC, NY, CA, GA, AR, KS, PA, NH, TX, OK, MA, MO, DC, AZ, IN, NJ, TN, WA, VA, CT and the countries of CA, BE, SG, HK, TW, BR, MY, IN, BO, PE, JP, MX, CL, KR, UY, AU.
Location
San Jose, CA

Frequently Asked Questions

What product was recalled?
CD11b APC: ASR, REF: 340936, and CE, REF: 333143. Recalled by Becton, Dickinson and Company, BD Biosciences. Units affected: 464 Vials.
Why was this product recalled?
In vitro diagnostics product that impacts the quality of cell staining can cause low or dim fluorescence signal, which can lead to potential false negative results and misdiagnosis of hematological malignancy, delayed treatment, and the need for additional patient samples.
Which agency issued this recall?
This recall was issued by the FDA Devices on January 17, 2024. Severity: Moderate. Recall number: Z-0641-2024.